Leading Hair Restoration Surgeon Sharon Keene, MD, Joins Advisory Board Of HairDX

First Consumer Genetic Test For Baldness: Affordable, Accurate,
Understandable Analysis Offered By Biotech Start-up
IRVINE, Calif.--(Business Wire)--Leading hair restoration surgeon Sharon Keene, MD, today joined
the Advisory Board of HairDX, LLC (www.HairDX.com), a biotech start-up
offering the first genetic baldness test for consumers.

HairDX recently launched a simple genetic test for consumers to
measure their risk for early onset pattern baldness (Androgenetic
Alopecia) and learn about their genetic predisposition to baldness
before the age of 40. The test was developed based on results from
several peer-reviewed scientific studies associating variations in the
X -chromosome to pattern baldness. The studies compared this variant
in bald and non bald patients.

HairDX is the first genetic test available to consumers as a
marker to help assess their risk for developing androgenetic alopecia
(male pattern baldness). This offers useful information to patients
who may wish to seek medical evaluation and treatment for increased
hair shedding when it is most cosmetically successful - before
substantial hair loss has occurred.

"HairDX tests for a genetic variant found in more than 95% of bald
men. 60% of patients with this variant experienced male pattern
baldness before the age of 40, thus it is a marker for a significant
increased risk of pattern baldness," says Professor Doron Lancet, PhD,
a pioneer of genome research and Head of the Crown Human Genome Center
at the Department of Molecular Genetics, Weizmann Institute of Science
in Rehovot, Israel. "This is in contrast to the less common genetic
variant of the same gene, present in about 1 in 6 people, which
indicates a greater then 85% likelihood that a person will not
experience early onset pattern baldness."

"The two FDA approved medications for treatment of androgenetic
alopecia are most effective at stopping or slowing hair loss rather
than regrowth of lost hairs. Unfortunately, by the time a patient can
actually see a pattern developing, he may have lost more than 50% of
the hair in the thinning area," says Keene. "The HairDX test can help
male patients at any age determine if they are at increased risk for
hair loss due to genetics, and to then learn about available treatment
options, before hair loss becomes advanced."

Keene is President and Medical Director of Physician's Hair
Institute, in Tucson, Arizona and is nationally recognized for her
pioneering work in the hair transplant field. She was the Program
Chair for the September, 2007 International Society of Hair
Restoration Surgeon's (ISHRS) conference in Las Vegas.

Keene is certified by the American Board of Surgery, and is a
member of the, the International Society of Hair Restoration Surgery,
the European Society of Hair Restoration Surgery, the Italian Society
of Hair Restoration Surgery (ISHRS), the International Alliance of
Hair Restoration Surgeons and Coalition of Independent Hair
Restoration Surgeons. She is currently acting chairman of the Evidence
Based Medicine Task force for the ISHRS.

"We are pleased to have a distinguished medical professional as
Dr. Keene join HairDX," says HairDX CEO Andy Goren. "This is a
powerful statement about genetic testing for early onset pattern
baldness."

About HairDX

HairDX was founded by leading researchers and specialists in
genetic analysis and hair therapies. The company is dedicated to
helping people make the right decisions about hair care, treatment and
restoration by providing accurate and accessible personalized
scientific information.

Among HairDX founders is William V. Murray former Division
President of the Molecular Biology Division of Applied BioSystems,
Inc., who formerly served in various executive leadership positions
within Medtronic, Andy Goren former CEO of MobileWise, Inc. and GeePS,
Inc., Eran Goren, CEO of enCircle Media, Inc., Professor Doron Lancet,
PhD, Head of the Crown Human Genome Center at the Department of
Molecular Genetics, Weizmann Institute of Science, Dr. Peter Novak, a
Neurologist at the University of Massachusetts Medical Center, and
Elliott J. Stein, an intellectual property attorney and co-founder of
GeePS, Inc. HairDX, LLC is a subsidiary of myGenopedia, Inc.

More information is available at www.hairdx.com

HairDX, LLC
Jon Boroshok, 978-502-1055
Public Relations
jonb@hairdx.com

Copyright Business Wire 2008